AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 283: E259-E266, 2002. First published March 27, 2002; doi:10.1152/ajpendo.00178.2001
0193-1849/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/2/E259    most recent
00178.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vella, A.
Right arrow Articles by Rizza, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vella, A.
Right arrow Articles by Rizza, R. A.
Vol. 283, Issue 2, E259-E266, August 2002

Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans

Adrian Vella1, Pankaj Shah1, Rita Basu1, Ananda Basu1, Michael Camilleri2, W. Frederick Schwenk3, and Robert A. Rizza1

Divisions of 1 Endocrinology, Metabolism, and Nutrition and 2 Gastroenterology, Departments of Internal Medicine and 3 Pediatrics and Adolescent Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905

To determine if enteral delivery of glucose influences splanchnic glucose metabolism, 10 subjects were studied when glucose was either infused into the duodenum at a rate of 22 µmol · kg-1 · min-1 and supplemental glucose given intravenously or when all glucose was infused intravenously while saline was infused intraduodenally. Hormone secretion was inhibited with somatostatin, and glucose (~8.5 mmol/l) and insulin (~450 pmol/l) were maintained at constant but elevated levels. Intravenously infused [6,6-2H2]glucose was used to trace the systemic appearance of intraduodenally infused [3-3H]glucose, whereas UDP-glucose flux (an index of hepatic glycogen synthesis) was measured using the acetaminophen glucuronide method. Despite differences in the route of glucose delivery, glucose production (3.5 ± 1.0 vs. 3.3 ± 1.0 µmol · kg-1 · min-1) and glucose disappearance (78.9 ± 5.7 vs. 85.0 ± 7.2 µmol · kg-1 · min-1) were comparable on intraduodenal and intravenous study days. Initial splanchnic glucose extraction (17.5 ± 4.4 vs. 14.5 ± 2.9%) and hepatic UDP-glucose flux (9.0 ± 2.0 vs. 10.3 ± 1.5 µmol · kg-1 · min-1) also did not differ on the intraduodenal and intravenous study days. These data argue against the existence of an "enteric" factor that directly (i.e., independently of circulating hormone concentrations) enhances splanchnic glucose uptake or hepatic glycogen synthesis in nondiabetic humans.

splanchnic glucose metabolism; postprandial hyperglycemia; acetaminophen glucuronide; hepatic glycogen synthesis; enteric signal


This article has been cited by other articles:


Home page
 J Clin PharmacolHome page
P. M. Jauslin, H. E. Silber, N. Frey, R. Gieschke, U. S. H. Simonsson, K. Jorga, and M. O. Karlsson
An Integrated Glucose-Insulin Model to Describe Oral Glucose Tolerance Test Data in Type 2 Diabetics
J. Clin. Pharmacol., October 1, 2007; 47(10): 1244 - 1255.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F.-Y. Chueh, C. Malabanan, and O. P. McGuinness
Impact of portal glucose delivery on glucose metabolism in conscious, unrestrained mice
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1206 - E1211.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Fery, L. Tappy, J. Deviere, and E. O. Balasse
Comparison of intraduodenal and intravenous glucose metabolism under clamp conditions in humans
Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E176 - E183.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Zangeneh, R. Basu, P. Shah, P. Arora, M. Camilleri, and R. A. Rizza
Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia
Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E280 - E286.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online